Slows the Decline in Kidney Function People with chronic kidney disease often lose kidney function at a steady rate
Insulin resistance, lipid metabolism imbalance to bile acids metabolism, gut-liver axis, apoptosis, and mitochondrial dysfunction were targeted separately, and as a result some drugs reached phase III clinical trials but failed at demonstrating superiority against placebo
Two main strategies have been used to modify the sequences of semaglutide and tirzepatide (red circles) and increase their bioavailability: 1) removal of the DPP-4 cleavage site, replacing alanine with an analogous molecule (-aminoisobutyric acid (Aib)), but not recognized by the enzyme
Then, scientists checked in with those participants for 1 year
Additionally, S-Acetyl-L-glutathione has demonstrated potential in inducing apoptosis in some tumor cell lines, suggesting its utility in oxidative stress and cancer therapy